1. Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study. Issue 3 (March 2020) Authors: Benson, Al B.; Strosberg, Jonathan; Joish, Vijay N.; Dharba, Samyukta; Sapre, Dipa; Lapuerta, Pablo Journal: Pancreas Issue: Volume 49:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗